vs

Side-by-side financial comparison of Madison Square Garden Entertainment Corp. (MSGE) and Penumbra Inc (PEN). Click either name above to swap in a different company.

Madison Square Garden Entertainment Corp. is the larger business by last-quarter revenue ($424.8M vs $385.4M, roughly 1.1× Penumbra Inc). Madison Square Garden Entertainment Corp. runs the higher net margin — 21.8% vs 12.3%, a 9.5% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 12.5%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs 17.6%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

MSGE vs PEN — Head-to-Head

Bigger by revenue
MSGE
MSGE
1.1× larger
MSGE
$424.8M
$385.4M
PEN
Growing faster (revenue YoY)
PEN
PEN
+9.6% gap
PEN
22.1%
12.5%
MSGE
Higher net margin
MSGE
MSGE
9.5% more per $
MSGE
21.8%
12.3%
PEN
Faster 2-yr revenue CAGR
MSGE
MSGE
Annualised
MSGE
48.9%
17.6%
PEN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSGE
MSGE
PEN
PEN
Revenue
$424.8M
$385.4M
Net Profit
$92.7M
$47.3M
Gross Margin
68.0%
Operating Margin
38.6%
15.4%
Net Margin
21.8%
12.3%
Revenue YoY
12.5%
22.1%
Net Profit YoY
22.2%
40.6%
EPS (diluted)
$1.94
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGE
MSGE
PEN
PEN
Q4 25
$424.8M
$385.4M
Q3 25
$154.1M
$354.7M
Q2 25
$145.1M
$339.5M
Q1 25
$206.0M
$324.1M
Q4 24
$377.6M
$315.5M
Q3 24
$134.1M
$301.0M
Q2 24
$177.6M
$299.4M
Q1 24
$191.6M
$278.7M
Net Profit
MSGE
MSGE
PEN
PEN
Q4 25
$92.7M
$47.3M
Q3 25
$-21.7M
$45.9M
Q2 25
$-27.2M
$45.3M
Q1 25
$8.0M
$39.2M
Q4 24
$75.9M
$33.7M
Q3 24
$-19.3M
$29.5M
Q2 24
$66.9M
$-60.2M
Q1 24
$2.8M
$11.0M
Gross Margin
MSGE
MSGE
PEN
PEN
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Q1 24
65.0%
Operating Margin
MSGE
MSGE
PEN
PEN
Q4 25
38.6%
15.4%
Q3 25
-19.3%
13.8%
Q2 25
-17.7%
12.0%
Q1 25
13.3%
12.4%
Q4 24
36.8%
13.6%
Q3 24
-13.8%
11.7%
Q2 24
-5.0%
-27.0%
Q1 24
8.8%
4.3%
Net Margin
MSGE
MSGE
PEN
PEN
Q4 25
21.8%
12.3%
Q3 25
-14.0%
12.9%
Q2 25
-18.7%
13.3%
Q1 25
3.9%
12.1%
Q4 24
20.1%
10.7%
Q3 24
-14.4%
9.8%
Q2 24
37.7%
-20.1%
Q1 24
1.5%
3.9%
EPS (diluted)
MSGE
MSGE
PEN
PEN
Q4 25
$1.94
$1.20
Q3 25
$-0.46
$1.17
Q2 25
$-0.56
$1.15
Q1 25
$0.17
$1.00
Q4 24
$1.56
$0.88
Q3 24
$-0.40
$0.75
Q2 24
$1.32
$-1.55
Q1 24
$0.06
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGE
MSGE
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$157.1M
$186.9M
Total DebtLower is stronger
$554.6M
Stockholders' EquityBook value
$36.0M
$1.4B
Total Assets
$1.8B
$1.8B
Debt / EquityLower = less leverage
15.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGE
MSGE
PEN
PEN
Q4 25
$157.1M
$186.9M
Q3 25
$29.9M
$321.0M
Q2 25
$43.0M
$421.8M
Q1 25
$89.0M
$376.1M
Q4 24
$54.9M
$324.4M
Q3 24
$37.3M
$280.5M
Q2 24
$33.3M
$288.3M
Q1 24
$28.0M
$223.1M
Total Debt
MSGE
MSGE
PEN
PEN
Q4 25
$554.6M
Q3 25
$581.7M
Q2 25
$568.8M
Q1 25
$577.4M
Q4 24
$584.7M
Q3 24
$647.0M
Q2 24
$599.2M
Q1 24
$602.5M
Stockholders' Equity
MSGE
MSGE
PEN
PEN
Q4 25
$36.0M
$1.4B
Q3 25
$-65.8M
$1.4B
Q2 25
$-13.3M
$1.3B
Q1 25
$9.5M
$1.2B
Q4 24
$10.3M
$1.2B
Q3 24
$-48.7M
$1.1B
Q2 24
$-23.2M
$1.2B
Q1 24
$-94.6M
$1.2B
Total Assets
MSGE
MSGE
PEN
PEN
Q4 25
$1.8B
$1.8B
Q3 25
$1.7B
$1.7B
Q2 25
$1.7B
$1.7B
Q1 25
$1.7B
$1.6B
Q4 24
$1.6B
$1.5B
Q3 24
$1.6B
$1.5B
Q2 24
$1.6B
$1.5B
Q1 24
$1.5B
$1.6B
Debt / Equity
MSGE
MSGE
PEN
PEN
Q4 25
15.40×
Q3 25
Q2 25
Q1 25
60.61×
Q4 24
56.61×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGE
MSGE
PEN
PEN
Operating Cash FlowLast quarter
$164.4M
$86.5M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.77×
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGE
MSGE
PEN
PEN
Q4 25
$164.4M
$86.5M
Q3 25
$19.8M
$58.3M
Q2 25
$-27.0M
$44.9M
Q1 25
$56.8M
$49.0M
Q4 24
$112.9M
$51.1M
Q3 24
$-27.4M
$56.5M
Q2 24
$212.0K
$22.6M
Q1 24
$5.8M
$38.3M
Free Cash Flow
MSGE
MSGE
PEN
PEN
Q4 25
$68.0M
Q3 25
$42.0M
Q2 25
$29.4M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
Q2 24
$18.1M
Q1 24
$32.5M
FCF Margin
MSGE
MSGE
PEN
PEN
Q4 25
17.7%
Q3 25
11.8%
Q2 25
8.7%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
Q2 24
6.0%
Q1 24
11.7%
Capex Intensity
MSGE
MSGE
PEN
PEN
Q4 25
4.8%
Q3 25
4.6%
Q2 25
4.6%
Q1 25
4.2%
Q4 24
1.7%
Q3 24
1.8%
Q2 24
1.5%
Q1 24
2.1%
Cash Conversion
MSGE
MSGE
PEN
PEN
Q4 25
1.77×
1.83×
Q3 25
1.27×
Q2 25
0.99×
Q1 25
7.07×
1.25×
Q4 24
1.49×
1.52×
Q3 24
1.91×
Q2 24
0.00×
Q1 24
2.08×
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGE
MSGE

Ticketing And Venue License Fee Revenues$263.5M62%
Food Beverage And Merchandise Revenues$64.3M15%
Related Party$43.9M10%
Arena Licensing Fees And Other Leasing Revenue$35.2M8%
Other$15.9M4%

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons